Specific Drug Use-results Surveillance (Long-term) for Erenumab in Migraine Patients in Japan (20210048)

26/01/2022
22/05/2024
EU PAS number:
EUPAS45236
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol-Published Original erenumab 20210048 .pdf

English (1.98 MB - PDF) View document
Study results
Study report
Other information